Elixirgen Therapeutics and Taisho Pharmaceutical tie-up to cure ageing-associated diseases
Taisho Pharmaceutical will bring its experience and expertise in the research and development of therapeutic products to the collaboration.
Taisho Pharmaceutical will bring its experience and expertise in the research and development of therapeutic products to the collaboration.
The single-dose vaccine has been approved in China, Mexico, Ecuador, Chile, Argentina, Hungary, Kirghizstan, Pakistan, Indonesia and Malaysia
Acute therapies continue to report strong growth compared to chronic ones.
Subscribe To Our Newsletter & Stay Updated